Townsend & Associates’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,313
Closed -$220K 121
2022
Q4
$220K Sell
1,313
-645
-33% -$87.7K 0.11% 106
2022
Q3
$263K Buy
+1,958
New +$246K 0.12% 72
2022
Q2
Sell
-1,793
Closed -$270K 86
2022
Q1
$270K Buy
+1,793
New +$220K 0.12% 72
2021
Q3
Sell
-2,794
Closed -$273K 72
2021
Q2
$273K Buy
2,794
+11
+0.4% +$1.03K 0.16% 66
2021
Q1
$223K Buy
+2,783
New +$169K 0.14% 67
2018
Q4
Sell
-2,269
Closed -$144K 121
2018
Q3
$144K Buy
2,269
+362
+19% +$23.2K 0.14% 89
2018
Q2
$119K Sell
1,907
-31
-2% -$1.98K 0.13% 88
2018
Q1
$118K Buy
1,938
+139
+8% +$9.21K 0.09% 83
2017
Q4
$114K Buy
+1,799
New +$105K 0.1% 89

Other funds holding NUE

Townsend & Associates's NUE Position: Q1 2023 in Review

Townsend & Associates sold out of Nucor (NUE) in Q1 2023, closing a stake of 1,313 shares — an estimated $220K sold.

Townsend & Associates first reported a position in NUE in Q4 2017 and held it in 9 quarters. The position peaked at $273K in Q2 2021. 1,189 funds tracked by Wall St. Rank hold NUE as of Q1 2023.

  • Townsend & Associates reported no remaining Nucor position as of Q1 2023 after selling out during the quarter.
  • Townsend & Associates sold 1,313 Nucor shares in Q1 2023, an estimated $220K.
  • Townsend & Associates first reported a position in Nucor in Q4 2017 and held it in 9 quarters.
  • Townsend & Associates's Nucor position peaked at $273K in Q2 2021.
  • 1,189 funds tracked by Wall St. Rank held Nucor as of Q1 2023.

Based on Townsend & Associates's 13F filing for Q1 2023, filed 15 May 2023.